Pharmafile Logo

payer survey

Sanofi reception

Sanofi bolsters pipeline with $3.7bn deal for Principia Biopharma

French drugmaker will gain access to a portfolio of BTK inhibitors

- PMLiVE

Vaccine nationalism must be prevented, says WHO director-general

Tedros Adhanom Ghebreyesus warns against supply nationalism

- PMLiVE

Matt Hancock unveils new National Institute for Health Protection

Public Health England to be replaced with new government body

- PMLiVE

Evoke KYNE promotes Dante DelVecchio to senior VP

DelVecchio takes on the role after ten years at Evoke KYNE

- PMLiVE

McCann Health North America appoints Jim Joseph as president

Joseph will oversee all North American advertising and promotion agencies in the US and Canada

- PMLiVE

BMS pays $475m for Dragonfly’s IL-12 immunotherapy programme

Agreement will focus on development in oncology and haematology

- PMLiVE

A senior level promotion in scientific services at Porterhouse Medical

Porterhouse is delighted to announce the promotion of Emma Conran

Porterhouse Medical Group

- PMLiVE

US states claim Purdue Pharma owes $2.2 trillion over opioid crisis

Company faces new accusations of dishonest marketing tactics

AstraZeneca AZ

AZ scores FDA priority review for new Imfinzi fixed-dose regimen

Four-week dosing schedule offers new flexibility for patients

Roche Basel Switzerland

Roche’s Soliris rival Enspryng bags FDA approval

Drug is second to be approved for the treatment of NMOSD

AstraZeneca AZ

AZ inks deal with EU for 400 million doses of COVID-19 vaccine

Doses will be available to all EU member states at no profit during pandemic

- PMLiVE

Public Health England to be axed over coronavirus response

Report from The Sunday Telegraph details plans to replace agency

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links